pantoloc 20 mg enterotabletter
takeda pharma a/s - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg
pantoloc 40 mg enterotabletter
takeda pharma a/s - pantoprazolnatriumsesquihydrat - enterotabletter - 40 mg
pantoloc 40 mg pulver til injektionsvæske, opløsning
takeda pharma a/s - pantoprazolnatriumsesquihydrat - pulver til injektionsvæske, opløsning - 40 mg
vepicombin novum 1,5 mill. ie filmovertrukne tabletter
takeda pharma a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1,5 mill. ie
vepicombin novum 1 mill. ie filmovertrukne tabletter
takeda pharma a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1 mill. ie
xefo 8 mg pulver og solvens til injektionsvæske, opløsning
takeda pharma a/s - lornoxicam - pulver og solvens til injektionsvæske, opløsning - 8 mg
equasym depot 10 mg kapsler med modificeret udløsning, hårde
2care4 aps - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 10 mg
alunbrig
takeda pharma a/s - brigatinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
elvanse 20 mg kapsler, hårde
2care4 aps - lisdexamfetamindimesilat - kapsler, hårde - 20 mg
elvanse 30 mg kapsler, hårde
2care4 aps - lisdexamfetamindimesilat - kapsler, hårde - 30 mg